Hi! I'm Priya
I completed my PhD in Oncology and Cancer Biology at Nirma University, where I studied how altering the structure of cytokines like IL-12 and chimeric IL-15 can be harnessed to fight cancer. With 3+ years of prior biosimilars R&D experience at Sun Pharma, I bridge structural biology, bioinformatics, and translational research.
I'm a structural biologist and cancer researcher driven by one question: can we reshape the proteins in our own body to fight tumors more effectively? That curiosity has shaped my entire career, from the lab bench to the research podium.
My journey started with a Bachelor of Science at Pramukhswami Medical College, Karamsad, followed by a Master's in Biotechnology at Nirma University, where I graduated with an A+ grade. That foundation set the stage for everything that followed.
I spent over three years at Sun Pharma as a Senior Scientist in Biosimilars R&D, where I developed a clone for aflibercept and worked on bevacizumab, IL-23, and GLP-2 projects. The experience of building novel biologics from the ground up, from cell line development to process optimization, gave me deep expertise in cell culture, molecular biology, and translational research.
I recently completed my PhD in Oncology and Cancer Biology at Nirma University under Prof Sarat Dalai in the Immunology Lab. My doctoral research explored structural biology and cancer: specifically, how we can alter the inherent structure of proteins that are present in the healthy body and apply that understanding to fight cancer. Cytokines, especially IL-12 and chimeric IL-15, were central to my doctoral work, and I used bioinformatics approaches to study how mutations drive structural changes in these proteins.
Along the way, I built extensive hands-on experience with structural biology and bioinformatics tools, including PyMOL, UCSF Chimera, ICM-Pro, Swiss-Model, AutoDock, and AutoDock Vina. I also served as a Senior Research Fellow with the Gujarat State Biotechnology Mission during my doctoral studies.
When I'm not in the lab, you'll find me at conferences sharing my work, reading the latest immuno-oncology literature, or mentoring students who are just beginning their research journey.
For the full career details, check out my LinkedIn.
I believe science grows through sharing. Here are conferences where I've presented my work, along with my published research on structural biology and cancer immunotherapy.
Presented a poster on cytokine-based immunotherapy approaches targeting the tumor microenvironment, covering signaling, metabolism, imaging, and therapeutic targets.
View conference details →5 publications across immuno-oncology, pharmaceutical biotechnology, epidemiology, and diagnostics. View more on ResearchGate.
A comprehensive volume on emerging innovations in pharmaceutical biotechnology. Published by CRC Press, November 2025.
Read on CRC Press → Immuno-OncologyA review of interleukin signaling in cancer biology and its therapeutic applications. Published in the World Journal of Biology Pharmacy and Health Sciences, August 2024.
Read publication → COVID-19A book chapter covering vaccine development strategies and approaches for COVID-19. Published by Bentham Books, August 2021.
Read on Bentham Books → EpidemiologyA population-level study on diabetes prevalence and risk factors in Gujarat. Published in the Journal of Diabetes, February 2021.
Read on PubMed → DiagnosticsEvaluating liposome-based diagnostic approaches for TB detection. Published in Expert Review of Molecular Diagnostics, May 2020.
Read on PubMed →
Selected by the Gujarat State Biotechnology Mission to advance cytokine immunotherapy research in oncology, with dedicated funding for IL-12 and chimeric IL-15-based cancer studies.
Completed doctoral research at Nirma University under Prof Sarat Dalai, focusing on structural biology of cytokines (IL-12, chimeric IL-15) and their role in cancer immunotherapy.
Presented research at the 9th International Conference on Tumor Microenvironment and Cellular Stress in Kalamata, Greece.
3+ years developing novel biologics at India's largest pharma company. Developed a clone for aflibercept and worked on bevacizumab, IL-23, and GLP-2 projects.
Graduated with an A+ grade from Nirma University, building a strong foundation in microbiology, protein purification, and molecular biology.
Completed B.S. at Pramukhswami Medical College, Karamsad with an A grade, specializing in microbiology and biochemistry.
Science keeps me busy, but animals keep me grounded. Meet Charlie, Kitlu, and every furry friend in between.
Whether you want to discuss immuno-oncology research, potential collaborations, or just say hello, I'd love to hear from you.